Bill Status of HB1720

  1. Home
  2. Legislation
  3. Bill Status

HB1720 - 104th General Assembly

TIANEPTINE PROHIBITION ACT
Last Action
1/28/2025 - House: Referred to Rules Committee
House Sponsors
Rep. Amy Elik
Statutes Amended In Order of Appearance
New Act
Synopsis As Introduced
Creates the Retail Sale of Tianeptine Prohibition Act. Provides that beginning January 1, 2026, no person shall sell, offer to sell, or distribute in the State any product containing tianeptine. Provides that the Act does not apply to any product containing tianeptine that is lawfully dispensed or prescribed by a pharmacist or a health care professional. Provides that a violation is a business offense, punishable by a minimum fine of $1,500 for each violation. Defines "health care professional". Effective January 1, 2026.
Actions
Date Chamber Action
1/24/2025 House Filed with the Clerk by Rep. Amy Elik
1/28/2025 House First Reading
1/28/2025 House Referred to Rules Committee